November 02-04, 2015 Baltimore, USA
November 10-12, 2016 Cartagena, Colombia
November 13-15, 2017 Washington, D.C., USA
13-15 November, 2018 Baltimore, MD
November 18-20, 2019 Boston, MA
August 09, 2021
I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.
Rino Rappuoli, Chief Scientist & Head of External Research and Development, GSK Vaccines
Nathalie Garçon, Chief Executive and Scientific Officer, IRT BIOASTER
It was really a great meeting this year, with an impressive roster of speakers the day I attended.
Jay A. Berzofsky, Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute
Congratulations. You have really made progress, and the meeting is getting better each time
Stephen L. Hoffman, Chief Executive and Scientific Officer, Sanaria Inc.
Thank you, I learned much at this meeting and made many new contacts
Michael G. Hanna, Founder and Chairman Emeritus, Vaccinogen Inc.
The meeting is getting better every year. Great work in organizing the speaker line
Farshad Guirakhoo, Chief Scientific Officer, GeoVax, Inc.
The first one was pretty bad but they have gotten progressively better. I thought Vaccine R&D2018 in Baltimore was well worth attending
Andrew Lees, Scientific Director, Owner, Fina BioSolutions LLC
Year of Foundation